Skip to main content
. 2020 Dec 31;11(1):46. doi: 10.3390/biom11010046

Figure 1.

Figure 1

(a) Schematic rational design of a suramin fragment and deoxycholic acid conjugate (SFD) representing binding to the heparin-binding site of vascular epithelial growth factor (VEGF) compared to a heparin fragment deoxycholic acid conjugate (HFD). (b) The surface charge of the SFD and HFD show similarities in molecular binding.